Form 8-K - Current report:
SEC Accession No. 0001213900-25-043706
Filing Date
2025-05-15
Accepted
2025-05-15 08:10:22
Documents
15
Period of Report
2025-05-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0242329-8k_incannex.htm   iXBRL 8-K 27657
2 PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED MAY 15, 2025 ea024232901ex99-1_incannex.htm EX-99.1 71964
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2915
  Complete submission text file 0001213900-25-043706.txt   289355

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ixhl-20250515.xsd EX-101.SCH 3023
5 XBRL LABEL FILE ixhl-20250515_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE ixhl-20250515_pre.xml EX-101.PRE 22364
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0242329-8k_incannex_htm.xml XML 3787
Mailing Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153
Business Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 25948845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)